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ABSTRACT
Cartilage is considered to be a simple tissue that should be
easy to engineer because it is avascular and contains just
one cell type, the chondrocyte. Despite this apparent sim-
plicity, regenerating cartilage in a form that can function
effectively after implantation in the joint has proven difﬁ-
cult. This may be because we have not fully appreciated
the importance of different structural regions of articular
cartilage or of understanding the origins of chondrocytes
and how this cell population is maintained in the normal
tissue. This review considers what is known about differ-
ent regions of cartilage and the types of stem cells in artic-
ulating joints and emphasizes the potential importance of
regeneration of the lamina splendens at the joint surface
and calciﬁed cartilage at the junction with bone for long-
term survival of regenerated tissue in vivo. STEM CELLS
2010;28:1992–1996
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INTRODUCTION
Damaged cartilage is considered by those of us who study it
to be an ideal case for tissue engineering because it has no
blood vessels or neurons, just chondrocytes. These enigmatic
cells are obligate anaerobes and so are capable of withstand-
ing the low oxygen tension of an avascular tissue. Cartilage is
considered to be a simple structure, not only because of its
single cell type but also because its extracellular matrix
(ECM) is primarily accounted for by three molecules: water,
type II collagen, and the large aggregating proteoglycan,
aggrecan. This biochemical composition is uniquely suited to
providing a combination of tensile strength with deformabil-
ity, giving it mechanical properties that resemble those of a
shock absorber [1], thereby dissipating forces across the
bones, preventing them from fracturing during normal activ-
ity. The balance between mechanical stiffness and ﬂexibility
is itself the result of interaction between the thin type II colla-
gen ﬁbrils, giving tensile strength, within which are trapped
molecules of aggrecan, which are highly negatively charged
and so bind water avidly [1]. When unloaded, the water con-
tent of cartilage is about 70% of the wet weight. Under
deforming load water ﬂows out and when the load is reduced
it ﬂows back in, damping the effects of these forces. Damage
to either the type II collagen or aggrecan may lead to loss of
cartilage function [2, 3]. If cartilage is to be engineered in the
laboratory or repaired in vivo then the balance between colla-
gen and proteoglycan must be restored to provide proper
function. The capacity of newly implanted cartilage to survive
without vascular in-growth combined with the relative sim-
plicity of its ECM has made a compelling case for develop-
ment of therapeutic strategies based on cartilage regeneration.
The main structural feature of the ECM is hyaline cartilage,
characterized by its glassy appearance when viewed under
polarized light microscopy (Fig. 1A). This is also the major
component of repair tissue in many patients [4]. The interface
of hyaline cartilage and subchondral bone is bridged by
calciﬁed cartilage and this tissue is itself separated from the
hyaline tissue by a proteoglycan-depleted tide-mark (Fig. 1B).
The articular surface of intact cartilage consists of a distinct
lamina splendens (Fig. 1C). Figure 2 shows the organizational
relationship between these different regions of articular carti-
lage within the joint. The focus of most cartilage tissue
engineering strategies has been on regenerating hyaline tissue
and yet there is good reason to think that reconstruction of
both the calciﬁed cartilage and lamina splendens will be
necessary for long-term survival of implants. This review
focuses on the calciﬁed cartilage and lamina splendens and
suggests that different types of stem cell will be required to
reproduce these structures in regenerating tissue.
CURRENT APPROACHES TO CARTILAGE
REGENERATION
Joint arthroplasty (the surgical implantation of artiﬁcial joints
such as hips) is a highly successful intervention for osteo-
arthritis (OA) [5] but may lead to long-term pain [6] and
aseptic loosening [7]. Tissue engineering could provide a
step-change in OA treatment as it can allow healing of the
natural joint, delaying the need for arthroplasty by several
years or perhaps avoiding it altogether. Autologous
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neering approach, was ﬁrst described by Brittberg et al. [8, 9],
with very good results for most patients treated over 9 years
[9]. The technique involves expanding chondrocytes, taken
from a biopsy of the patient’s own cartilage, and injecting the
cell suspension underneath a periosteal ﬂap or collagen mem-
brane, sutured over the lesion. It was a ground-breaking
approach to cartilage repair that opened up the ﬁeld of tissue
engineering. However, it remains unclear if ACI offers a sig-
niﬁcant advantage over the simpler surgical technique of
microfracture [10], which involves bleeding the subchondral
bone at the lesion site to invoke clot formation. One explana-
tion of this limited success of ACI may be that in most joint
compartments of the knee focal cartilage lesions have a
greater than 60% chance of increasing in size over a 2-year
follow-up period [11]. Indeed, Poole et al. [12] have proposed
that focal articular cartilage lesions represent the development
of early OA. Regeneration of a mature, stable ECM can take
as long as 1-2 years after ACI treatment [9], during which
time the lesions may continue to increase in size. Therefore
implantation of cartilage that has been pre-engineered in cul-
ture may prevent the growth in size of focal articular cartilage
lesions in a way that is not possible with ACI. Indeed, chon-
drocytes precultured on scaffolds and implanted ectopically in
nude mice generated better hyaline cartilage than cells
implanted on scaffolds without preculture [13] and chondro-
cytes precultured on scaffolds for 14 days generated hyaline
cartilage even when implanted in patients with preexisting
early OA [4].
STEM CELLS AND CARTILAGE REGENERATION
The next logical step is to engineer and implant cartilage with
a more extensive ECM [14, 15] and with an architecture that
more closely resembles the natural tissue. Moreover, this
mature implant will need to integrate with the surrounding
host cartilage to survive and function [16]. Such an approach
will require a sophisticated understanding of cartilage struc-
ture in development, maturity, and pathology. Scaling up
tissue engineering therapies for the treatment of large num-
bers of patients will also ideally involve the use of allogeneic
cells that can grow in vitro through multiple population dou-
blings without senescing or transforming and can then differ-
entiate into chondrocytes, produce appropriate matrix, and
survive in vivo without immune rejection. However, the artic-
ular cartilage of joints sits on a rigid bony surface and is
exposed to very high forces during normal daily activity [17].
The structure of any repair cartilage must therefore withstand
these forces and implanted stem cells must respond appropri-
ately to the loads since stiffness of the underlying tissue can
have a marked impact on differentiation fate decisions [18].
Mesenchymal stem cells (MSCs) may be the ideal cell
type for this purpose. Bone marrow-derived MSCs have been
the most widely studied since their ﬁrst isolation [19]. We
have shown their potential for chondrogenic differentiation
and tissue engineering [14, 15]. They are hypoimmunogenic
[20–23] and immunosuppressive [21, 23] and so can create a
zone of immune tolerance around the site in which they are
implanted [20, 21]. However, MSCs or MSC-like progenitors
can be found within different tissues of the joint and these
may have some advantages over the bonemarrow-derived
cells in cartilage repair. Understanding the similarities and
differences between these different stem cells may be crucial
for effective articular cartilage regeneration.
If stem cells are to be the biological source of new carti-
lage then we must be able to control their differentiation so
that they generate functional chondrocytes (the cells of carti-
lage) that can orchestrate the formation of an appropriate
ECM. This has been the underlying principle of many
attempts at cartilage repair [15, 24].
However, creation of the osteochondral interface using
stem cells will require a detailed understanding of those
MSCs that are best able to differentiate to the hypertrophic
chondrocyte phenotype.
DEVELOPMENT AND REGENERATION
OF CALCIFIED CARTILAGE
Development of the Cartilage–Bone Interface
The cartilage adjacent to bone is calciﬁed and like the calci-
ﬁed cartilage of the growth plate contains type X collagen.
Figure 1. Histological appearance of different zones of articular car-
tilage. (A): The typical glassy appearance of hyaline cartilage under
polarized light microscopy. (B): The calciﬁed cartilage zone and tide
mark at the cartilage–bone junction in hematoxylin and eosin stained
sections. (C): The lamina splendens at the surface of articular carti-
lage under polarized light microscopy. All panels were viewed at
10 magniﬁcation.
Figure 2. Diagram of the microstructure of articular cartilage found
in the joints.
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toxylin and eosin-stained sections, running parallel to the bone
surface (Fig. 1B) [25]. The elastic modulus of calciﬁed cartilage
is in the MPa range, compared with kPa values for hyaline carti-
lage and GPa for the underlying bone [26, 27]. These observa-
tions indicate the importance of calciﬁed tissue as a transition
between cartilage and bone. Engineered implants that have failed
to recreate this transition may fail under mechanical load.
Long bones start growing in the early stages of fetal de-
velopment, continuing in neonates, and through to skeletal
maturity. The mechanism of bone formation is endochondral
ossiﬁcation. An epiphyseal cartilage template is gradually
ossiﬁed at the primary and then secondary centers of ossiﬁca-
tion. Chondrocytes undergo terminal differentiation to hyper-
trophic chondrocytes that are positive for alkaline phosphatase
and type X collagen as well as for type II collagen and have
the capacity to mineralise their ECM [1]. As the hypertrophic
epiphyseal cartilage is calciﬁed, a process of vascular invasion
leads to repopulation of the cartilage with osteoblasts that
remodel the calciﬁed cartilage into bone [1]. This process cre-
ates a continuum from cartilage to bone. After the growth
plates have closed and bone growth has ceased, the cartilage
remains as a thin layer at the end of the bone (the articulating
surface) and the cartilage–bone interface is characterized by
calciﬁed cartilage that differs from hypertrophic cartilage in
the growth plate because it is not normally invaded by blood
vessels and therefore it does not remodel to bone. The chon-
drocytes in and adjacent to the calciﬁed cartilage produce
both type X collagen [28] and alkaline phosphatase [29].
Engineering the Cartilage–Bone Interface
Tissue engineering may be able to generate calciﬁed cartilage
at the hyaline cartilage–subchondral bone interface through a
combination of appropriate use of biomaterial scaffolds, careful
selection of speciﬁc progenitor cells, and regulation of biome-
chanical signaling in vitro either through biomaterial stiffness
or through loading regimes in purpose-designed bioreactors
[18, 30, 31]. However, this would create a further problem of
how to integrate engineered calciﬁed cartilage with natural sub-
chondral bone. Therefore, a more realistic approach may be to
rely on the mechanical and growth factor signals within the in
vivo implantation site as the most important regulatory factors,
driving maturation of the tissue in situ [32]. Bone marrow-
derived MSCs are thought to have an inherent tendency to dif-
ferentiate to hypertrophic chondrocytes; however, recent in
vivo studies [33, 34] have suggested that on implantation into
articular cartilage they only terminally differentiate in the deep
zone adjacent to bone, whereas in more superﬁcial zones they
are arrested in a prehypertrophic state by the local production
of parathyroid hormone-related protein (PTHrP). Therefore, use
of bone marrow-derived MSCs rather than chondrocytes may
provide a simple solution to the problem of creating a zone of
calciﬁed cartilage. On the other hand, loss of the surface zone
of articular cartilage in OA may mean there is no PTHrP pro-
duction leading to aberrant calciﬁcation throughout the implant
side. Therefore, an understanding of the stem cell properties
and the nature of the implant site will be critical for ensuring
an effective tissue engineering outcome.
DEVELOPMENT AND REGENERATION OF THE
SURFACE OF ARTICULATING CARTILAGE
Development of the Surface Zone
At the very surface of articulating cartilage is the lamina
splendens in which collagen ﬁbrils run parallel to the surface
of articulation [35]. This surface zone layer is likely to play a
key role in maintaining the mechanical response of articular
cartilage to load [36]. It is the ﬁrst region of cartilage to
degrade in OA [37, 38] and there is no evidence that it is
regenerated when chondrocytes are implanted into lesion sites
[4, 39]. This is a signiﬁcant limitation that, unless resolved,
may lead to the ultimate failure of any articular cartilage
implant as a result of the shear forces in the joint. For this
reason, it is critical to understand the role of the surface zone
of cartilage in development, joint function, and pathology. It
is also essential to consider the importance of repair strategies
that can result in regeneration of the surface zone.
Hayes et al. [40] explored the shift during cartilage devel-
opment from a relatively simple isotropic tissue with a high
cell density and homogeneous distribution of collagen ﬁbrils
to an anisotropic tissue with a low density of chondrocytes
growing in vertical columns and a unique arrangement of col-
lagen ﬁbrils. They studied these changes in the marsupial
‘‘Monodelphis Domestica’’ because of its short gestation and
primitive stage of development at birth. They concluded that
the tissue develops through appositional growth from the
articular surface with a gradual fall in cell density in the sur-
face zone as the dividing progenitor cells undergo asymmetric
division, giving rise to transit-amplifying cells. The same
team went on to isolate progenitor cells from the surface zone
of 7-day-old bovine calf articular cartilage [41, 42]. They
were isolated based on their ability to bind well to ﬁbronectin
and to form colonies with greater efﬁciency than chondrocytes
from elsewhere (or compared with those cells not binding to
ﬁbronectin). They characterized the cells as being positive for
notch 1. Lineage-labeled cells were able to differentiate into
musculoskeletal tissues when implanted into chick eggs. They
can continue to grow in vitro for up to 50 population dou-
blings (approximately 17 passages) before showing signs of
senescence. The growth kinetics of these cells are typically
very rapid at ﬁrst but then slowing down. In contrast, the
chondrocyte population in general shows linear growth
kinetics irrespective of time in culture. The chondrogenic
potential of the surface zone progenitor cells is maintained
right through to late passage, until senescence.
The origin of these surface zone progenitor cells and the
extent to which they persist into maturity remains unknown.
These issues were explored further by Karlsson et al. [43]
who investigated stem cell populations throughout the joints
of skeletally mature 3-month-old rabbits. In particular, they
identiﬁed the zone of Ranvier as a potential MSC niche in the
joint. This zone is located at the edge of the growth plate of
long bones in rabbits. These cells are positive for Jagged-1
and Stro-1. Importantly, stem cells in the articular cartilage
itself were not found just at the surface but throughout the
cartilage at relatively low density. This contrasts with the pre-
vious ﬁndings of surface zone chondroprogenitors in 7-day-
old calves [41, 42]. Karlsson et al. conclude that the articular
cartilage chondroprogenitor cells are derived from migration
of mesenchymal cells out of the zone of Ranvier niche. They
hypothesize that in early development these cells may accu-
mulate in the surface zone and drive the process of apposi-
tional growth of cartilage but with maturity they become
dissipated throughout the cartilage. These observations may
explain why lesions in the articular surface of cartilage may
heal spontaneously in immature animals [44] whereas in adult
animals there is no evidence of spontaneous healing [45].
Thus, the surface zone of articular cartilage is a critical
component of the mature tissue because its collagen ﬁbrils are
oriented parallel to the plane of the tissue surface and so
endow it with resistance to shear forces in the joint. It is also
a critical component of the immature tissue because it drives
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there is ﬁbrillation at the surface [41–43]. It follows that
tissue-engineered cartilage implants that do not have a lamina
splendens will not function mechanically in the same way as
the natural tissue because they will lack resistance to shear
forces. Establishing a zone of type II collagen ﬁbrils in the
appropriate orientation at the surface should be a key aim of
any cartilage engineering strategy. Furthermore, the long-term
survival of engineered implants in the hostile environment of
an osteoarthritic joint may depend on the capacity to establish
a population of progenitor cells within the surface zone that
can drive a repair process when damage has accrued. It is im-
portant to note that at least one study [46] has shown a lack
of type II collagen in this zone. Instead the parallel bundles
of collagen ﬁbrils were found to be composed of collagen
types I and III. Therefore, the chondroprogenitors in this zone
may have a characteristic collagen synthesis phenotype that is
different to cells found elsewhere in articular cartilage.
Engineering the Surface of Cartilage
Enriching the surface of engineered implants with mesenchy-
mal cells derived from the synovial membrane may be a way
of reconstructing the lamina splendens. De Bari isolated mes-
enchymal cells from the synovial tissue of adult humans and
showed them to have the capacity to undergo chondrogenic,
osteogenic, adipogenic, and myogenic differentiation [47, 48].
He went on to isolate clones of synovial membrane progenitor
cells that were able to grow for 25–50 population doublings
before undergoing senescence. These clones were negative for
markers of hematopoetic stem cells (CD45) and endothelial
cells (CD31) but positive (with variable expression) for MSC
markers CD13, CD105, CD73, CD166, SSEA4, CD81, and
CD90. Thus, the synovium-derived cells are compatible with
an MSC phenotype. All the clones were chondrogenic in pel-
let cultures, even at late passage, as well as osteogenic,
whereas adipogenesis was more variable.
Lee et al. made the interesting and potentially important
observation that after chondrogenic differentiation, synovial
membrane-derived progenitors secrete lubricin, also known as
‘‘surface zone protein’’ [49]. This glycoprotein protects the
articular surface-adherent proteins from cell inﬁltration as
well as providing boundary lubrication that may be critical
for mechanical function of the joint [50]. Lubricin is also
found at the surface of other joint tissues such as ligaments
[50]. The synovial membrane synthesizes synovial ﬂuid that
bathes the surface of all joint structures and so the synovial
membrane-ﬂuid pathway may provide a route for synovial
MSCs to migrate between different tissues of the joint, differ-
entiate, and (at the surface) secrete lubricin. Whether these
cells also participate in the maintenance of the lamina splen-
dens is not known. However, the concept of seeding synovial
MSCs onto the surface of engineered cartilage to create a
lubricin-rich zone is attractive and may at least enhance the
mechanical function of the biological implants.
SUMMARY
Loss of the surface zone early in OA may be devastating
because it will remove the main driver of the appositional
growth of cartilage. Failure of repair of the lamina splendens
may reﬂect a failure of this niche to function normally in the
injured adult joint, leading ultimately to cartilage erosion and
loss of joint function. Tissue engineering solutions will most
likely require a recreation of the surface zone if the implants
are to survive without rapid degradation. Similarly, recreation
of the calciﬁed cartilage that interfaces the osteochondral
junction is likely to be essential for the avoidance of delami-
nation as a result of shear forces focusing stresses at this site.
Cartilage is a simple tissue that is full of complexity and this
must be reﬂected in our stem cell and tissue engineering
strategies.
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